Watch Ticker

Celcuity Inc. Common Stock

Go to Celcuity Inc. Common Stock Website

$43.00

3.09 (7.74%)

Live

Previous Close

$39.91

Day Range

$38.93 - $43.73

Previous Day Range

$38.0001 - $40.88

Market Cap

$1.6 billion USD

Day Vol.

1.9 million

Previous Day Vol.

1.6 million

Currency

USD

Primary Exchange

Nasdaq

Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Biotech Underdogs Line Up for Pivotal Shots at Game-Changing Cancer Treatments

Several biotech companies are developing innovative cancer treatments, with promising clinical trial results in various cancer types, focusing on immunotherapy and personalized medicine approaches.

Related tickers: ONCY, CELC, LYEL, EVAX, AGEN.

Read Full Article

Prnewswire - Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention

Cancer research companies are attracting investor interest as the oncology market is projected to grow significantly, with several firms showing promising clinical trial results and strategic developments in cancer treatments.

Related tickers: CELC, CTOR, EXEL.

Read Full Article

Trending Tickers

Please sign in to view